GENinCode Plc (LON:GENI – Get Free Report) shares were down 9.3% during trading on Wednesday . The company traded as low as GBX 6 ($0.08) and last traded at GBX 6.12 ($0.08). Approximately 157,011 shares changed hands during mid-day trading, a decline of 41% from the average daily volume of 264,602 shares. The stock had previously closed at GBX 6.75 ($0.09).
GENinCode Price Performance
The company has a debt-to-equity ratio of 6.74, a quick ratio of 15.89 and a current ratio of 5.92. The stock has a 50 day moving average price of GBX 7.41 and a 200 day moving average price of GBX 6.13. The company has a market cap of £11.06 million, a P/E ratio of -104.17 and a beta of 0.62.
GENinCode Company Profile
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Further Reading
- Five stocks we like better than GENinCode
- How to Invest in Insurance Companies: A Guide
- Sales Breakout Sends This Semiconductor Stock to Record High
- How to Calculate Options Profits
- Surprise Buying Opportunity on This Dividend Aristocrat
- How to Calculate Retirement Income: MarketBeat’s Calculator
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
